Description
Derived from a breast cancer biopsy removed from a 48 year-old female. The histology of the breast cancer biopsy was defined as Ductal Grade III, tumour cells did not stain positive for oestrogen receptors. The VP267 cell line was derived from the same individual as the cell line VP229. VP229 was derived from the primary tumour and VP267 was derived 14 months later from a local recurrence of the tumour. The individual was recorded to live for 1year after surgery performed to remove the tumour. The patient had received tamoxifen treatment. This cell line grows slowly and is relatively difficult to culture; please read the sub-culture routine information closely.
Adherent Suspension
Adherent
Suggested Medium
MEBM (Clonetics, CC-3151) + MEGM SingleQuots (Clonetics, CC-4136) + 2mM Glutamine + 2% Foetal Bovine Serum (FBS). Fresh EGF (final concentration of 10ng/ml) should be added to the medium at each subculture.
Quality Control
VP267 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Shippment
VP267 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
VP267 Cell Line is for research use only
